Ultimovacs ASA (ULTI OL) stock market data APIs
kr15.7435
0.89(6%)
as of April 4, 2025
Ultimovacs ASA Financial Data Overview
Ultimovacs ASA, a biotech company, develops immunotherapies against cancers in Norway. Its lead product candidate is UV1, a peptide-based therapeutic cancer vaccine that induces a specific T cell response against the pan-tumor antigen telomerase. Ultimovacs ASA was incorporated in 2011 and is headquartered in Oslo, Norway.
Prev. Close
14.8529
Open
15.7435
High
15.7435
Low
14.5287
52 wk Range
14.6-120.2
Market Cap
70 533 K
Shares Outstanding
34 406 K
EPS
-3.1307
Beta
0.785
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Ultimovacs ASA data using free add-ons & libraries
Get Ultimovacs ASA Fundamental Data
Ultimovacs ASA Fundamental data includes:
- Net Revenue:
- EBITDA: -148 488 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-01-31
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Ultimovacs ASA News
New
Ultimovacs Announces Resignation of Aitana Peire from Board of Directors
Oslo, November 28, 2023: Ultimovacs ASA ("Ultimovacs") (OSE ULTI), a clinical-stage biotechnology leader in novel immunotherapeutic cancer vaccines, today announces that Aitana Peire, Ph.D., has notif...
Ultimovacs ASA: Mandatory notification of trade by primary insider
Oslo, 21 November 2023, a closely related party of Carlos de Sousa, Chief Executive Officer and primary insider in Ultimovacs ASA, has today bought 500 shares in the company at an average price of NOK...
Ultimovacs ASA: New share capital registered
Oslo, 13 November 2023, Ultimovacs ASA (the "Company") refers to the announcement published on 9 November 2023 regarding the issuance of new shares in connection with the Company's employee incentive ...
Ultimovacs ASA: Share capital increase related to exercise of options
Oslo, 09 November 2023, the Board of Directors of Ultimovacs ASA (the "Company") has resolved to increase the Company's share capital by NOK 960 through the issuance of 9,600 new shares, each with a p...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
